Investor's $70M Suit V. Abbott Sent To Arbitration
An appellate court has dismissed a $70 million lawsuit accusing Abbott Laboratories of cheating a Cayman Islands-based investment firm out of royalties when the pharmaceutical company stopped developing the ZoMaxx stent,...To view the full article, register now.
Already a subscriber? Click here to view full article